OTTAWA, ON- Stem cell and regenerative medicine experts representing Canada and international research groups are coming together in Ottawa to share some of the leading advances in research, clinical translation and commercialization within the field.
A number of speakers, including eight past winners of Canada’s most recognized stem cell prize – the Till & McCulloch Award – will be present at the Till & McCulloch Meetings (#TMM2014). The meetings, co-hosted by the Stem Cell Network and the Centre for Commercialization of Regenerative Medicine (CCRM), are taking place this week at the Westin Ottawa .
Also presenting is this year’s Award winner, Dr. Michael Rudnicki, senior scientist and director of the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute, whose research in muscle regeneration, specifically in the role stem cells play in skeletal muscles’ ability to regenerate and repair after injury, will be recognized on October 29 at 9:50 a.m. in the main plenary hall.
“To be chosen by your peers to receive the Till & McCulloch Award is a great honour, made finer by the fact that it will take place in my home city of Ottawa,” said Dr. Rudnicki, who is also the scientific director of the Stem Cell Network. “Ottawa is a fantastic place to live and conduct research and we are excited to show this to our Canadian and international guests over the course of the conference.”
The 2014 Till & McCulloch Meetings is also a celebration of achievement for the Stem Cell Network, which is in its final year of funding as a federal Network of Centres of Excellence. Based in Ottawa for its entire term, the Stem Cell Network engaged more than 120 researchers and 1,900 students across Canada, catalyzed 15 clinical trials and leveraged more than $87 million in advancing research from the laboratory to the clinic.
Some of the key individuals making presentations include:
- Dr. John Dick, of the Princess Margaret Hospital in Toronto, will present some of his latest findings in a lecture entitled, “Stem cells in cancer: Do they matter?” Dr. Dick is a globally-recognized leader in the investigation of cancer stem cells and their role in the formation and relapse of cancer.
- Dr. Guy Sauvageau (University of Montreal), whose breakthrough discovery of a new drug to expand the number of usable stem cells in cord blood recently made headlines around the world. Dr. Sauvageau will provide insight into this discovery.
- Professor Timothy Caulfield (University of Alberta) will present his research into the pressures, risks and benefits of the “culture of innovation” that drives research into greater commercial applications.
The 2014 Meetings will also feature the launch of two new animated videos in the award-winning StemCellShorts series, to be launched online and via social media (#StemCellShorts) during the conference. In addition, on October 29 a glimpse of the recently opened Super Cells science exhibit (www.supercells.ca), and the announcement of the winner of the annual Cells I See art contest (www.cellsisee.ca) will take place.
To learn more about the Till & McCulloch Meetings click here.